Neurocrine Biosciences reported $225.9M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
ALKERMES ALKS:US $ 452.98M 69.54M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Amgen AMGN:US $ 14842M 257M
Aptinyx Inc APTX:US $ 6.28M 2.9M
Biogen BIIB:US $ 4211.6M 864.4M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Cytokinetics CYTK:US $ 80.87M 19.1M
Dynavax Technologies DVAX:US $ 528.93M 324.29M
Enanta Pharmaceuticals ENTA:US $ 36.17M 7.55M
Exelixis EXEL:US $ 269.51M 14.18M
Gilead Sciences GILD:US $ 10245M 31M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Halozyme Therapeutics HALO:US $ 113.15M 1.1M
Intra Cellular Therapies ITCI:US $ 49.9M 0.53M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Prothena PRTA:US 29.2M 23.7M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Repligen RGEN:US $ 349.44M 17.1M
Rigel Pharmaceuticals RIGL:US $ 59.28M 0.26M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Teva Pharmaceutical TEVA:IT 11.82B 866M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
Xoma XOMA:US $ 6.51M 221K
YTE INCY:US $ 742.71M 82.39M
Zogenix ZGNX:US $ 78.43M 9.09M